Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Kim, Se Ik ^a   Kim, Hee Seung ^a   Kim, Tae Hun ^b   Suh, Dong Hoon ^c   Kim, Kidong ^c   No, Jae Hong ^c   Chung, Hyun Hoon ^a   Kim, Yong Beom ^c   Song, Yong Sang ^a,d  

^a Seoul National University College of Medicine   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN;

ADULT; ADVANCED CANCER; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CYTOREDUCTIVE SURGERY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBESITY; OVARY CANCER; OVARY CARCINOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SPINAL SPACER; UNDERWEIGHT; UNIVERSITY HOSPITAL; WEIGHT REDUCTION; ADJUVANT THERAPY; ADOLESCENT; AGED; BODY WEIGHT; CANCER STAGING; COMORBIDITY; DISEASE COURSE; INFLAMMATION; MIDDLE AGED; MORTALITY; OVARIAN NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY MASS INDEX; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; THINNESS; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 84904206528     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/349546     Document Type: Article

References (33)

1. Renehan A. G., Tyson M., Egger M., Heller R. F., Zwahlen M., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet 2008 371 9612 569 578 10.1016/S0140-6736(08)60269-X 2-s2.0-38949108241 (Pubitemid 351232031)
2. Gilbert C. A., Slingerland J. M., Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annual Review of Medicine 2013 64 45 57 10.1146/annurev-med-121211-091527 2-s2.0-84873030540
3. Cowey S., Hardy R. W., The metabolic syndrome: a high-risk state for cancer? The American Journal of Pathology 2006 169 5 1505 1522 10.2353/ajpath.2006.051090 2-s2.0-33947653911 (Pubitemid 351181984)
4. Calle E. E., Kaaks R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer 2004 4 8 579 591 10.1038/nrc1408 2-s2.0-3543072186 (Pubitemid 39025053)
5. Gago-Dominguez M., Castelao J. E., Yuan J., Ross R. K., Yu M. C., Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes & Control 2002 13 3 287 293 10.1023/A:1015044518505 2-s2.0-0036226885 (Pubitemid 34438239)
6. Sparano J. A., Wang M., Zhao F., Stearns V., Martino S., Ligibel J. A., Perez E. A., Saphner T., Wolff A. C., Sledge G. W., Wood W. C., Fetting J., Davidson N. E., Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 2012 118 23 5937 5946 10.1002/cncr.27527 2-s2.0-84869507377
7. Ho T., Gerber L., Aronson W. J., Terris M. K., Presti J. C., Kane C. J., Amling C. L., Freedland S. J., Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. European Urology 2012 62 5 910 916 10.1016/j.eururo.2012.08.015 2-s2.0-84867069646
8. Moon H. G., Han W., Noh D. Y., Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society. Journal of Clinical Oncology 2009 27 35 5899 5905 10.1200/JCO.2009.22.4436 2-s2.0-73349095412
9. Protani M. M., Nagle C. M., Webb P. M., Obesity and ovarian cancer survival: a systematic review and meta-analysis. Cancer Prevention Research 2012 5 7 901 910 10.1158/1940-6207.CAPR-12-0048 2-s2.0-84866452518
10. Suh D. H., Kim J., Kim K., Kim H. J., Lee K., Major clinical research advances in gynecologic cancer in 2012. Journal of Gynecologic Oncology 2012 24 1 66 82 10.3802/jgo.2013.24.1.66 2-s2.0-84873033900
11. Claise B.,. Cisco systems NetFlow services export version 9
12. Cho H., Hur H. W., Kim S. W., Kim S. H., Kim J. H., Kim Y. T., Lee K., Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunology, Immunotherapy 2009 58 1 15 23 10.1007/s00262-008-0516-3 2-s2.0-54849431185
13. Thavaramara T., Phaloprakarn C., Tangjitgamol S., Manusirivithaya S., Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. Journal of the Medical Association of Thailand 2011 94 7 871 877 2-s2.0-79960053304
14. Kim H. S., Han K. H., Chung H. H., Kim J. W., Park N. H., Song Y. S., Kang S. B., Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. European Journal of Surgical Oncology 2010 36 7 691 698 10.1016/j.ejso.2010.05.004 2-s2.0-77953912251
15. Walsh S. R., Cook E. J., Goulder F., Justin T. A., Keeling N. J., Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. Journal of Surgical Oncology 2005 91 3 181 184 10.1002/jso.20329 2-s2.0-24344442821 (Pubitemid 41254421)
16. Louie S. M., Roberts L. S., Nomura D. K., Mechanisms linking obesity and cancer. Biochimica et Biophysica Acta 2013 1831 10 1499 1508 10.1016/j.bbalip.2013.02.008 2-s2.0-84876075126
17. Alberti K. G., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J., James W. P. T., Loria C. M., Smith S. C., Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; and international association for the study of obesity. Circulation 2009 120 16 1640 1645 10.1161/CIRCULATIONAHA.109. 192644 2-s2.0-70350245011
18. Zhou J. R., Blackburn G. L., Walker W. A., Symposium introduction: metabolic syndrome and the onset of cancer. The American Journal of Clinical Nutrition 2007 86 3 S817 S819 2-s2.0-40349116042
19. Nicolucci A., Epidemiological aspects of neoplasms in diabetes. Acta Diabetologica 2010 47 2 87 95 10.1007/s00592-010-0187-3 2-s2.0-77952755480
20. Tan B. H. L., Fearon K. C. H., Cachexia: prevalence and impact in medicine. Current Opinion in Clinical Nutrition and Metabolic Care 2008 11 4 400 407 10.1097/MCO.0b013e328300ecc1 2-s2.0-54049125762
21. Morley J. E., Thomas D. R., Wilson M. M., Cachexia: pathophysiology and clinical relevance. The American Journal of Clinical Nutrition 2006 83 4 735 743 2-s2.0-33646674302 (Pubitemid 44713134)
22. Kalantar-Zadeh K., Horwich T. B., Oreopoulos A., Kovesdy C. P., Younessi H., Anker S. D., Morley J. E., Risk factor paradox in wasting diseases. Current Opinion in Clinical Nutrition and Metabolic Care 2007 10 4 433 442 10.1097/MCO.0b013e3281a30594 2-s2.0-34250633536 (Pubitemid 46934112)
23. Heintz A. P., Odicino F., Maisonneuve P., Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynaecology and Obstetrics 95 supplement 1 S161 S192
24. Suh D. H., Kim H. S., Chung H. H., Kim J. W., Park N. H., Song Y. S., Kang S., Body mass index and survival in patients with epithelial ovarian cancer. Journal of Obstetrics and Gynaecology Research 2012 38 1 70 76 10.1111/j.1447-0756.2011.01628.x 2-s2.0-84863055474
25. Tisdale M. J., Mechanisms of cancer cachexia. Physiological Reviews 2009 89 2 381 410 10.1152/physrev.00016.2008 2-s2.0-67649982995
26. Evans W. J., Morley J. E., Argilés J., Bales C., Baracos V., Guttridge D., Jatoi A., Kalantar-Zadeh K., Lochs H., Mantovani G., Marks D., Mitch W. E., Muscaritoli M., Najand A., Ponikowski P., Rossi Fanelli F., Schambelan M., Schols A., Schuster M., Thomas D., Wolfe R., Anker S. D., Cachexia: a new definition. Clinical Nutrition 2008 27 6 793 799 10.1016/j.clnu.2008.06.013 2-s2.0-55749085001
27. Evans W. J., Skeletal muscle loss: cachexia, sarcopenia, and inactivity. The American Journal of Clinical Nutrition 2010 91 4 1123S 1127S 10.3945/ajcn.2010.28608A 2-s2.0-77950485782
28. Argilés J. M., Busquets S., Felipe A., López-Soriano F. J., Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. The International Journal of Biochemistry & Cell Biology 2005 37 5 1084 1104 10.1016/j.biocel.2004.10.003 2-s2.0-14644404350 (Pubitemid 40311748)
29. Gullett N., Rossi P., Kucuk O., Johnstone P. A. S., Cancer-induced cachexia: a guide for the oncologist. Journal of the Society for Integrative Oncology 2009 7 4 155 169 10.2310/7200.2009.0018 2-s2.0-76649098527
30. Harvey A. E., Lashinger L. M., Hursting S. D., The growing challenge of obesity and cancer: an inflammatory issue. Annals of the New York Academy of Sciences 2011 1229 1 45 52 10.1111/j.1749-6632.2011.06096.x 2-s2.0-79960820132
31. Seidell J. C., Obesity, insulin resistance and diabetes-a worldwide epidemic. British Journal of Nutrition 2000 83 supplement 1 S5 S8 2-s2.0-0034109077 (Pubitemid 30319075)
32. Raji A., Seely E. W., Arky R. A., Simonson D. C., Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. The Journal of Clinical Endocrinology and Metabolism 2001 86 11 5366 5371 10.1210/jc.86.11.5366 2-s2.0-0035191137 (Pubitemid 33070261)
33. Karelis A. D., St-Pierre D. H., Conus F., Rabasa-Lhoret R., Poehlman E. T., Metabolic and body composition factors in subgroups of obesity: what do we know? The Journal of Clinical Endocrinology and Metabolism 2004 89 6 2569 2575 10.1210/jc.2004-0165 2-s2.0-2942657651 (Pubitemid 38766333)